Interferon-γ Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Women With Different Chlamydia Outcomes
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae092 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Jacob Dziadula und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections, Interferon-gamma, Bacterial Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
Chlamydia trachomatis testing and treatment strategies have not decreased infection rates, justifying need for a chlamydia vaccine. A murine study showed that a vaccine consisting of major outer membrane protein (MOMP) and polymorphic membrane proteins (Pmps) E, F, G, and H elicited protective immunity; studies on human cellular immune responses to Pmps are sparse.
Methods
Interferon gamma (IFN-γ) responses to these 5 proteins were measured by ELISPOT in peripheral blood mononuclear cells from women returning for treatment of a positive chlamydia test. Responses were compared in those with spontaneous chlamydia clearance versus persisting infection at baseline and no reinfection versus reinfection at a 3-month follow-up visit.
Results
IFN-γ response to 1 or more proteins was detected in 39% at baseline and 51.5% at follow-up, most often to PmpE and MOMP. IFN-γ responses to MOMP were detected less often at follow-up versus baseline in women with reinfection, but were maintained in those without reinfection. Women with spontaneous clearance had a higher magnitude of IFN-γ response to PmpE and MOMP.
Conclusions
IFN-γ responses to these 5 C. trachomatis vaccine candidate proteins were heterogenous and primarily directed against MOMP and PmpE. Spontaneous chlamydia clearance and absence of reinfection may be clinical correlates of protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- British Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: William M Geisler
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Dziadula, J., Sabbaj, S., Gupta, K., Cutter, G., Yu, H., Brunham, R. C., & Geisler, W. M. (2024). Interferon-γ Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Women With Different Chlamydia Outcomes. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae092
Vancouver
Dziadula J, Sabbaj S, Gupta K, Cutter G, Yu H, Brunham RC, et al. Interferon-γ Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Women With Different Chlamydia Outcomes. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae092
BibTeX
@article{Dziadula2024,
author = {Dziadula, Jacob and Sabbaj, Steffanie and Gupta, Kanupriya and Cutter, Gary and Yu, Hong and Brunham, Robert C and Geisler, William M},
title = {Interferon-γ Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Women With Different Chlamydia Outcomes},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae092}
}
EUVIMED